75 related articles for article (PubMed ID: 16917872)
1. A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells.
Crouthamel MH; Wu D; Yang Z; Ho RJ
J Pharm Sci; 2006 Dec; 95(12):2767-77. PubMed ID: 16917872
[TBL] [Abstract][Full Text] [Related]
2. A novel human multidrug resistance gene MDR1 variant G571A (G191R) modulates cancer drug resistance and efflux transport.
Yang Z; Wu D; Bui T; Ho RJ
J Pharmacol Exp Ther; 2008 Nov; 327(2):474-81. PubMed ID: 18723777
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein.
Woodahl EL; Yang Z; Bui T; Shen DD; Ho RJ
J Pharmacol Exp Ther; 2004 Sep; 310(3):1199-207. PubMed ID: 15100388
[TBL] [Abstract][Full Text] [Related]
4. MDR1 C2005T polymorphism changes substrate specificity.
Liu L; Fan L; Peng X; Hu D; Zhou H
Cancer Chemother Pharmacol; 2010 Aug; 66(3):617-23. PubMed ID: 20309692
[TBL] [Abstract][Full Text] [Related]
5. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells.
Salama NN; Yang Z; Bui T; Ho RJ
J Pharm Sci; 2006 Oct; 95(10):2293-308. PubMed ID: 16883550
[TBL] [Abstract][Full Text] [Related]
6. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
8. A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions.
Crouthamel MH; Wu D; Yang Z; Ho RJ
AAPS J; 2010 Dec; 12(4):548-55. PubMed ID: 20623213
[TBL] [Abstract][Full Text] [Related]
9. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
Woodahl EL; Crouthamel MH; Bui T; Shen DD; Ho RJ
Cancer Chemother Pharmacol; 2009 Jun; 64(1):183-8. PubMed ID: 19123050
[TBL] [Abstract][Full Text] [Related]
10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
11. MDR1 gene expression in myelodysplastic syndrome and in acute myeloid leukemia evolving from myelodysplastic syndrome.
Zöchbauer S; Gsur A; Götzl M; Wallner J; Lechner K; Pirker R
Anticancer Res; 1994; 14(3B):1293-5. PubMed ID: 7915092
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
Cho HJ; Choi MK; Lin H; Kim JS; Chung SJ; Shim CK; Kim DD
J Pharm Pharmacol; 2011 Mar; 63(3):385-91. PubMed ID: 21749386
[TBL] [Abstract][Full Text] [Related]
13. ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.
Gréen H; Söderkvist P; Rosenberg P; Horvath G; Peterson C
J Pharm Sci; 2008 Jun; 97(6):2045-8. PubMed ID: 17828752
[TBL] [Abstract][Full Text] [Related]
14. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
Wang R; Sun X; Deng YS; Qiu XW
Xenobiotica; 2019 Nov; 49(11):1373-1378. PubMed ID: 30587068
[TBL] [Abstract][Full Text] [Related]
15. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells.
Eid SY; El-Readi MZ; Eldin EE; Fatani SH; Wink M
Phytomedicine; 2013 Dec; 21(1):47-61. PubMed ID: 23999162
[TBL] [Abstract][Full Text] [Related]
16. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.
Pichler A; Zelcer N; Prior JL; Kuil AJ; Piwnica-Worms D
Clin Cancer Res; 2005 Jun; 11(12):4487-94. PubMed ID: 15958634
[TBL] [Abstract][Full Text] [Related]
17. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
Januchowski R; Wojtowicz K; Andrzejewska M; Zabel M
Biomed Pharmacother; 2014 Feb; 68(1):111-7. PubMed ID: 24140176
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
Yamagishi N; Nakao R; Kondo R; Nishitsuji M; Saito Y; Kuga T; Hatayama T; Nakayama Y
Biochem Biophys Res Commun; 2014 Jun; 448(4):430-6. PubMed ID: 24796664
[TBL] [Abstract][Full Text] [Related]
19. Xenopus laevis oocytes expressing human P-glycoprotein: probing trans- and cis-inhibitory effects on [3H]vinblastine and [3H]digoxin efflux.
Jutabha P; Wempe MF; Anzai N; Otomo J; Kadota T; Endou H
Pharmacol Res; 2010 Jan; 61(1):76-84. PubMed ID: 19631272
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
